{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:48:56Z","timestamp":1792014536757,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The present study was supported by the Hunan Provincial Health Commission 2019 Annual Scientific Research.","award":["C2019098"],"award-info":[{"award-number":["C2019098"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Accumulating evidence suggests a strong association between polycystic ovary syndrome (PCOS) and ovarian cancer (OC), but the potential molecular mechanism remains unclear. In this study, we identified previously unrecognized genes that are significantly correlated with PCOS and OC via bioinformatics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>Multiple bioinformatic analyses, such as differential expression analysis, univariate Cox analysis, functional and pathway enrichment analysis, protein\u2013protein interaction (PPI) network construction, survival analysis, and immune infiltration analysis, were utilized. We further evaluated the effect of OGN on FSHR expression via immunofluorescence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>TCGA-OC, GSE140082 (for OC) and GSE34526 (for PCOS) datasets were downloaded. Twelve genes, including RNF144B, LPAR3, CRISPLD2, JCHAIN, OR7E14P, IL27RA, PTPRD, STAT1, NR4A1, OGN, GALNT6 and CXCL11, were identified as signature genes. Drug sensitivity analysis showed that OGN might represent a hub gene in the progression of PCOS and OC. Experimental analysis found that OGN could increase FSHR expression, indicating that OGN could regulate the hormonal response in PCOS and OC. Furthermore, correlation analysis indicated that OGN function might be closely related to m6A and ferroptosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study identified a 12-gene signature that might be involved in the prognostic significance of OC. Furthermore, the hub gene OGN represent a significant gene involved in OC and PCOS progression by regulating the hormonal response.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-022-00962-w","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T17:03:04Z","timestamp":1646067784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Juan","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianchun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongcheng","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"962_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.lfs.2019.04.046","volume":"228","author":"Y Li","year":"2019","unstructured":"Li Y, et al. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci. 2019;228:167\u201375.","journal-title":"Life Sci"},{"issue":"1","key":"962_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12902-019-0356-5","volume":"19","author":"J Jiao","year":"2019","unstructured":"Jiao J, et al. Genetic and epigenetic characteristics in ovarian tissues from polycystic ovary syndrome patients with irregular menstruation resemble those of ovarian cancer. BMC Endocr Disord. 2019;19(1):30.","journal-title":"BMC Endocr Disord"},{"issue":"23","key":"962_CR3","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","volume":"90","author":"HA Risch","year":"1998","unstructured":"Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 1998;90(23):1774\u201386.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"962_CR4","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0015-0282(02)04346-7","volume":"78","author":"A la Marca","year":"2002","unstructured":"la Marca A, et al. Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. Fertil Steril. 2002;78(6):1234\u20139.","journal-title":"Fertil Steril"},{"issue":"2","key":"962_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/humupd\/dmh010","volume":"10","author":"S Jonard","year":"2004","unstructured":"Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update. 2004;10(2):107\u201317.","journal-title":"Hum Reprod Update"},{"issue":"10","key":"962_CR6","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1210\/me.2005-0479","volume":"20","author":"HV Heemers","year":"2006","unstructured":"Heemers HV, Verhoeven G, Swinnen JV. Androgen activation of the sterol regulatory element-binding protein pathway: Current insights. Mol Endocrinol. 2006;20(10):2265\u201377.","journal-title":"Mol Endocrinol"},{"issue":"7","key":"962_CR7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2337\/diab.42.7.1073","volume":"42","author":"A Holm\u00e4ng","year":"1993","unstructured":"Holm\u00e4ng A, Brzezinska Z, Bj\u00f6rntorp P. Effects of hyperinsulinemia on muscle fiber composition and capitalization in rats. Diabetes. 1993;42(7):1073\u201381.","journal-title":"Diabetes"},{"key":"962_CR8","first-page":"367","volume":"21","author":"KJ Ryan","year":"1965","unstructured":"Ryan KJ, Smith OW. BIOGENESIS OF STEROID HORMONES IN THE HUMAN OVARY. Recent Prog Horm Res. 1965;21:367\u2013409.","journal-title":"Recent Prog Horm Res"},{"issue":"6","key":"962_CR9","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00404-018-4762-0","volume":"297","author":"X Ruan","year":"2018","unstructured":"Ruan X, et al. Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients. Arch Gynecol Obstet. 2018;297(6):1557\u201363.","journal-title":"Arch Gynecol Obstet"},{"key":"962_CR10","doi-asserted-by":"publisher","first-page":"p 105498","DOI":"10.1016\/j.jsbmb.2019.105498","volume":"196","author":"A Kollara","year":"2020","unstructured":"Kollara A, et al. Increased androgen receptor levels and signaling in ovarian cancer cells by VEPH1 associated with suppression of SMAD3 and AKT activation. J Steroid Biochem Mol Biol. 2020;196:p 105498.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"962_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ygyno.2016.10.005","volume":"143","author":"ER Craig","year":"2016","unstructured":"Craig ER, et al. Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: A review. Gynecol Oncol. 2016;143(3):674\u201383.","journal-title":"Gynecol Oncol"},{"issue":"1A","key":"962_CR12","first-page":"A68","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak K, Czerwinska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015;19(1A):A68-77.","journal-title":"Contemp Oncol (Pozn)"},{"key":"962_CR13","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, et al. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013;41:D991-5.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"962_CR14","doi-asserted-by":"publisher","first-page":"E2016","DOI":"10.1210\/jc.2011-3441","volume":"97","author":"S Kaur","year":"2012","unstructured":"Kaur S, et al. Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis. J Clin Endocrinol Metab. 2012;97(10):E2016\u201321.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"962_CR15","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s43032-020-00352-x","volume":"28","author":"D Yang","year":"2021","unstructured":"Yang D, et al. Identification of Potential Biomarkers of Polycystic Ovary Syndrome via Integrated Bioinformatics Analysis. Reprod Sci. 2021;28(5):1353\u201361.","journal-title":"Reprod Sci"},{"key":"962_CR16","doi-asserted-by":"publisher","first-page":"585130","DOI":"10.3389\/fendo.2020.585130","volume":"11","author":"V Yumiceba","year":"2020","unstructured":"Yumiceba V, et al. Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis. Front Endocrinol (Lausanne). 2020;11:585130.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"962_CR17","doi-asserted-by":"crossref","unstructured":"Zhang QF, et al. Identification and validation of a prognostic index based on a metabolic-genomic landscape analysis of ovarian cancer. Biosci Rep. 2020;40(9).","DOI":"10.1042\/BSR20201937"},{"issue":"1","key":"962_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13048-020-0613-2","volume":"13","author":"D Yang","year":"2020","unstructured":"Yang D, et al. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. J Ovarian Res. 2020;13(1):10.","journal-title":"J Ovarian Res"},{"key":"962_CR19","unstructured":"The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45(6):580-5."},{"issue":"1","key":"962_CR20","doi-asserted-by":"publisher","first-page":"p. 44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da W, B.T. Sherman, R.A. Lempicki. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"key":"962_CR21","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:W214-20.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"962_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/path.2440","volume":"216","author":"F Pont\u00e9n","year":"2008","unstructured":"Pont\u00e9n F, Jirstr\u00f6m K, Uhlen M. The Human Protein Atlas\u2013a tool for pathology. J Pathol. 2008;216(4):387\u201393.","journal-title":"J Pathol"},{"issue":"9","key":"962_CR23","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1074\/mcp.TIR119.001673","volume":"18","author":"P Wu","year":"2019","unstructured":"Wu P, et al. Integration and Analysis of CPTAC Proteomics Data in the Context of Cancer Genomics in the cBioPortal. Mol Cell Proteomics. 2019;18(9):1893\u20138.","journal-title":"Mol Cell Proteomics"},{"issue":"W1","key":"962_CR24","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509-w514.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"962_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3727\/096504008786111383","volume":"17","author":"CK Bose","year":"2008","unstructured":"Bose CK. Follicle stimulating hormone receptor in ovarian surface epithelium and epithelial ovarian cancer. Oncol Res. 2008;17(5):231\u20138.","journal-title":"Oncol Res"},{"key":"962_CR26","unstructured":"Waghu FH, et al. FSHR antagonists can trigger a PCOS-like state. Syst Biol Reprod Med. 2021:1\u20139."},{"issue":"4","key":"962_CR27","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/med.21473","volume":"38","author":"C Thuwajit","year":"2018","unstructured":"Thuwajit C, et al. The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role. Med Res Rev. 2018;38(4):1235\u201354.","journal-title":"Med Res Rev"},{"key":"962_CR28","doi-asserted-by":"publisher","first-page":"109449","DOI":"10.1016\/j.biopha.2019.109449","volume":"120","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Jin Z, Wang C. Glycogen phosphorylase B promotes ovarian cancer progression via Wnt\/\u03b2-catenin signaling and is regulated by miR-133a-3p. Biomed Pharmacother. 2019;120:109449.","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"962_CR29","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.3390\/ijms22147748","volume":"22","author":"W.M. Chung","year":"2021","unstructured":"Chung W.M., et al. Androgen\/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials. Int J Mol Sci. 2021;22(14):7748.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"962_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13048-018-0403-2","volume":"11","author":"K Ling","year":"2018","unstructured":"Ling K, et al. Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR\/Cas9 system. J Ovarian Res. 2018;11(1):36.","journal-title":"J Ovarian Res"},{"issue":"1","key":"962_CR31","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1186\/s12885-016-2865-1","volume":"16","author":"X Yu","year":"2016","unstructured":"Yu X, Zhang Y, Chen H. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study. BMC Cancer. 2016;16(1):846.","journal-title":"BMC Cancer"},{"key":"962_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12935-020-01361-1","volume":"20","author":"J Chen","year":"2020","unstructured":"Chen J, et al. Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico. Cancer Cell Int. 2020;20:270.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"962_CR33","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/IGC.0000000000001193","volume":"28","author":"JA Josahkian","year":"2018","unstructured":"Josahkian JA, et al. Increased STAT1 Expression in High Grade Serous Ovarian Cancer Is Associated With a Better Outcome. Int J Gynecol Cancer. 2018;28(3):459\u201365.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"962_CR34","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ygyno.2016.02.030","volume":"141","author":"E Delgado","year":"2016","unstructured":"Delgado E, et al. High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome. Gynecol Oncol. 2016;141(2):348\u201356.","journal-title":"Gynecol Oncol"},{"issue":"15","key":"962_CR35","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1158\/0008-5472.CAN-12-4560","volume":"73","author":"AJ Wilson","year":"2013","unstructured":"Wilson AJ, et al. TR3 modulates platinum resistance in ovarian cancer. Cancer Res. 2013;73(15):4758\u201369.","journal-title":"Cancer Res"},{"issue":"26","key":"962_CR36","doi-asserted-by":"publisher","first-page":"42588","DOI":"10.18632\/oncotarget.16585","volume":"8","author":"TC Lin","year":"2017","unstructured":"Lin TC, et al. GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity. Oncotarget. 2017;8(26):42588\u2013601.","journal-title":"Oncotarget"},{"issue":"5","key":"962_CR37","doi-asserted-by":"publisher","first-page":"101042831770622","DOI":"10.1177\/1010428317706226","volume":"39","author":"YJ Koo","year":"2017","unstructured":"Koo YJ, et al. CXCL11 mediates TWIST1-induced angiogenesis in epithelial ovarian cancer. Tumour Biol. 2017;39(5):1010428317706226.","journal-title":"Tumour Biol"},{"issue":"1","key":"962_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/path.4258","volume":"232","author":"TS Lau","year":"2014","unstructured":"Lau TS, et al. Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts. J Pathol. 2014;232(1):43\u201356.","journal-title":"J Pathol"},{"issue":"1","key":"962_CR39","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1186\/s12885-020-07695-3","volume":"20","author":"S Yan","year":"2020","unstructured":"Yan S, et al. Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer. BMC Cancer. 2020;20(1):1205.","journal-title":"BMC Cancer"},{"issue":"1","key":"962_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12920-017-0308-8","volume":"10","author":"J Budczies","year":"2017","unstructured":"Budczies J, et al. Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types. BMC Med Genomics. 2017;10(1):74.","journal-title":"BMC Med Genomics"},{"issue":"12","key":"962_CR41","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00109-020-01985-w","volume":"98","author":"R Paravati","year":"2020","unstructured":"Paravati R, et al. Differential regulation of osteopontin and CD44 correlates with infertility status in PCOS patients. J Mol Med (Berl). 2020;98(12):1713\u201325.","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"962_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1210\/en.2017-00219","volume":"159","author":"M Wang","year":"2018","unstructured":"Wang M, et al. Functional Characterization of MicroRNA-27a-3p Expression in Human Polycystic Ovary Syndrome. Endocrinology. 2018;159(1):297\u2013309.","journal-title":"Endocrinology"},{"key":"962_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2019.05.015","volume":"113","author":"J Song","year":"2019","unstructured":"Song J, et al. Androgen upregulates NR4A1 via the TFAP2A and ETS signaling networks. Int J Biochem Cell Biol. 2019;113:1\u20137.","journal-title":"Int J Biochem Cell Biol"},{"issue":"11","key":"962_CR44","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1055\/a-0992-9114","volume":"128","author":"E Hatziagelaki","year":"2020","unstructured":"Hatziagelaki E, et al. Association between Biomarkers of Low-grade Inflammation and Sex Hormones in Women with Polycystic Ovary Syndrome. Exp Clin Endocrinol Diabetes. 2020;128(11):723\u201330.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1\u20132","key":"962_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1023\/A:1023487424751","volume":"246","author":"B Fern\u00e1ndez","year":"2003","unstructured":"Fern\u00e1ndez B, et al. Osteoglycin expression and localization in rabbit tissues and atherosclerotic plaques. Mol Cell Biochem. 2003;246(1\u20132):3\u201311.","journal-title":"Mol Cell Biochem"},{"key":"962_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ebiom.2018.07.021","volume":"34","author":"X Hu","year":"2018","unstructured":"Hu X, et al. Osteoglycin-induced VEGF Inhibition Enhances T Lymphocytes Infiltrating in Colorectal Cancer. EBioMedicine. 2018;34:35\u201345.","journal-title":"EBioMedicine"},{"issue":"6","key":"962_CR47","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1530\/REP-18-0323","volume":"157","author":"K Hummitzsch","year":"2019","unstructured":"Hummitzsch K, et al. Transcriptome analyses of ovarian stroma: tunica albuginea, interstitium and theca interna. Reproduction. 2019;157(6):545\u201365.","journal-title":"Reproduction"},{"key":"962_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s41065-019-0097-5","volume":"156","author":"Q Hao","year":"2019","unstructured":"Hao Q, et al. Proteomic characterization of bovine granulosa cells in dominant and subordinate follicles. Hereditas. 2019;156:21.","journal-title":"Hereditas"},{"issue":"1","key":"962_CR49","doi-asserted-by":"publisher","first-page":"13834","DOI":"10.1038\/s41598-020-70896-0","volume":"10","author":"K Song","year":"2020","unstructured":"Song K, et al. Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase. Sci Rep. 2020;10(1):13834.","journal-title":"Sci Rep"},{"issue":"19","key":"962_CR50","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1038\/onc.2015.316","volume":"35","author":"J Chen","year":"2016","unstructured":"Chen J, et al. Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K\/AKT\/HIF-1\u03b1\/cyclin D1 pathway. Oncogene. 2016;35(19):2506\u201317.","journal-title":"Oncogene"},{"issue":"3","key":"962_CR51","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.bbrc.2015.04.061","volume":"461","author":"L Liu","year":"2015","unstructured":"Liu L, et al. OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1\/2 signaling pathway in epithelial ovarian cancer. Biochem Biophys Res Commun. 2015;461(3):525\u201332.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"962_CR52","doi-asserted-by":"publisher","first-page":"e2476","DOI":"10.1038\/cddis.2016.379","volume":"7","author":"X Du","year":"2016","unstructured":"Du X, et al. TGF-\u03b2 signaling controls FSHR signaling-reduced ovarian granulosa cell apoptosis through the SMAD4\/miR-143 axis. Cell Death Dis. 2016;7(11):e2476.","journal-title":"Cell Death Dis"},{"issue":"12","key":"962_CR53","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1210\/jc.2019-00780","volume":"104","author":"LA Owens","year":"2019","unstructured":"Owens LA, et al. Gene Expression in Granulosa Cells From Small Antral Follicles From Women With or Without Polycystic Ovaries. J Clin Endocrinol Metab. 2019;104(12):6182\u201392.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"962_CR54","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1172\/JCI2081","volume":"101","author":"KA Vendola","year":"1998","unstructured":"Vendola KA, et al. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest. 1998;101(12):2622\u20139.","journal-title":"J Clin Invest"},{"issue":"4","key":"962_CR55","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1210\/en.2016-1538","volume":"158","author":"M Laird","year":"2017","unstructured":"Laird M, et al. Androgen Stimulates Growth of Mouse Preantral Follicles In Vitro: Interaction With Follicle-Stimulating Hormone and With Growth Factors of the TGF\u03b2 Superfamily. Endocrinology. 2017;158(4):920\u201335.","journal-title":"Endocrinology"},{"issue":"2","key":"962_CR56","first-page":"584","volume":"12","author":"H Chen","year":"2019","unstructured":"Chen H, Yang L, Sun W. Elevated OGN expression correlates with the EMT signature and poor prognosis in ovarian carcinoma. Int J Clin Exp Pathol. 2019;12(2):584\u20139.","journal-title":"Int J Clin Exp Pathol"},{"key":"962_CR57","doi-asserted-by":"publisher","first-page":"665945","DOI":"10.3389\/fonc.2021.665945","volume":"11","author":"L Li","year":"2021","unstructured":"Li L, et al. Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy. Front Oncol. 2021;11:665945.","journal-title":"Front Oncol"},{"issue":"1","key":"962_CR58","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1186\/s12935-021-02371-3","volume":"21","author":"LL Chang","year":"2021","unstructured":"Chang LL, et al. Emerging role of m6A methylation modification in ovarian cancer. Cancer Cell Int. 2021;21(1):663.","journal-title":"Cancer Cell Int"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-00962-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-022-00962-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-00962-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T08:12:51Z","timestamp":1666426371000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-022-00962-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["962"],"URL":"https:\/\/doi.org\/10.1186\/s13048-022-00962-w","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}